PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: Colivelin
Colivelin is a synthetic hybrid neuroprotective peptide that fuses activity-dependent neurotrophic factor (ADNF) with a potent Humanin derivative, studied for protecting neurons against amyloid-beta and other neurotoxic insults.
Sign in to rate this peptide.
Colivelin is a fusion of the ADNF-derived peptide and a stabilized Humanin analog (AGA-(C8R)-HNG17), combining two neuroprotective modules into one molecule. It activates pro-survival signaling, notably the STAT3 pathway, and engages Humanin-associated receptor systems to suppress neuronal apoptosis induced by amyloid-beta, mutant familial Alzheimer genes, and prion fragments. By upregulating anti-apoptotic signaling at femtomolar to picomolar concentrations, it protects cholinergic and other neurons and has shown memory-preserving effects in rodent models.